(Q36018749)

11 August 2017

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo (English)

1 reference

Mycobacterium tuberculosis

11 August 2017

0 references

7

Laura E Via

1 reference

11 August 2017

Clifton E Barry

8

0 references

author name string

Kathleen England

1

1 reference

11 August 2017

Helena I M Boshoff

2

1 reference

11 August 2017

Kriti Arora

3

1 reference

11 August 2017

Danielle Weiner

4

1 reference

11 August 2017

Emmanuel Dayao

5

1 reference

11 August 2017

Daniel Schimel

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

26 March 2012

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

56

1 reference

11 August 2017

6

1 reference

11 August 2017

3384-3387

1 reference

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Meropenem: a review of its use in the treatment of serious bacterial infections.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Carbapenems: a potent class of antibiotics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

A review of the antimicrobial activity of clavulanate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Meropenem: a microbiological overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

The pharmacokinetics of meropenem in volunteers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Safety evaluation of meropenem in animals: studies on the kidney

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370771

The entry of meropenem into human macrophages and its immunomodulating activity

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450968

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stability of a 1.BETA.-Methylcarbapenem Antibiotic, Meropenem(SM-7338) in Aqueous Solution

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450968

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The disposition and metabolism of meropenem in laboratory animals and man

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450968

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.05690-11

1 reference

11 August 2017

1 reference

11 August 2017

1 reference